Abstract:A CagA-positive Helicobacter pylori (H. pylori) infection can cause malignant transformation of human gastric mucosal epithelial cells, and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) is a chemical carcinogen that induces gastric carcinogenesis. Whether this environmental chemocarcinogen may synergistically enhance the risk of H. pylori-infected gastric cancer remains unclear. In this study, we adopted a chronic CagA-positive H. pylori infection with or without MNNG coinduction to establish a cellular model in GES-1 cells and an animal model in C57BL/6J mice. The proliferation, cell phenotype, apoptosis, epithelial-mesenchymal transition (EMT), stemness and tumorigenicity of gastric mucosal epithelial cells were analyzed in vitro and in vivo. The results showed that chronic H. pylori-infected GES-1 cells displayed inhibited apoptosis, abnormal proliferation, enhanced invasion, and migration, increased EMT/mesenchymal phenotype, colony formation and stem cell-like properties, and enhanced tumorsphere-formatting efficiency as well as CD44 expression, a known gastric cancer stem cell (CSC) marker. MNNG synergistically promoted the above actions of chronic H. pylori infection. Further studies in chronic H. pylori-infected C57BL/6J mice models showed that an increased incidence of premalignant lesions in the gastric mucosa tissue of the H. pylori-infected mice had occurred, the mouse gastric mucosa cells exhibited similar mesenchymal and CSC-like properties in the above GES-1 cells, and precancerous lesions and EMT/CSC-like phenotypes were reinforced by the synergistic action of MNNG stimulation. H. pylori infection and/or MNNG induction were capable of causing enhanced expression and activation of Wnt2 and beta-catenin, indicating that the Wnt/beta-catenin pathway is involved in the actions of H. pylori and MNNG. Taken together, these findings suggest that chronic CagA-positive H. pylori infection with MNNG stimulation synergistically induces mesenchymal and CSC-like properties of gastric mucosal epithelial cells.

Mir-374 Mediates the Malignant Transformation of Gastric Cancer-Associated Mesenchymal Stem Cells in an Experimental Rat Model

Restoration Of Mir-1228*Expression Suppresses Epithelial-Mesenchymal Transition In Gastric Cancer

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Gastric Cancer-Derived Mesenchymal Stem Cells Promote Gastric Cancer Cell Lines Migration by Modulating CD276 Expression

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.

Downregulation of Mirna-146A-5p Promotes Malignant Transformation of Mesenchymal Stromal/stem Cells by Glioma Stem-Like Cells.

Tumor-Educated Neutrophils Activate Mesenchymal Stem Cells to Promote Gastric Cancer Growth and Metastasis

Mesenchymal Stem Cells Promote Epithelial to Mesenchymal Transition and Metastasis in Gastric Cancer Though Paracrine Cues and Close Physical Contact.

Tumorigenic Hybrids Between Mesenchymal Stem Cells and Gastric Cancer Cells Enhanced Cancer Proliferation, Migration and Stemness

miR-1555 p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p 65 activation

Integration of Exosomal Mir-106A and Mesothelial Cells Facilitates Gastric Cancer Peritoneal Dissemination.

Mir-373 Suppresses Gastric Cancer Metastasis by Downregulating Vimentin.

Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful

Effects of Mir‑138‑5p and Mir‑204‑5p on the Migration and Proliferation of Gastric Cancer Cells by Targeting EGFR.

Chronic CagA-positive Helicobacter Pylori Infection with MNNG Stimulation Synergistically Induces Mesenchymal and Cancer Stem Cell-Like Properties in Gastric Mucosal Epithelial Cells

Mesenchymal Stem Cells in Cancer: a New Link to Neutrophils

IL22 Furthers Malignant Transformation of Rat Mesenchymal Stem Cells, Possibly in Association with IL22RA1/STAT3 Signaling

Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition Via Upregulation Tregs Ratio and PD-1 Expression in CD4+T Cell.

Long-term MNNG exposure promotes gastric carcinogenesis by activating METTL3/m6A/miR1184 axis-mediated epithelial-mesenchymal transition

Gastric Cancer Mesenchymal Stem Cells Regulate PD-L1-CTCF Enhancing Cancer Stem Cell-Like Properties and Tumorigenesis